The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Paclitaxel/carboplatin with or without cetuximab for treatment of carcinoma with unknown primary (PACET-CUP): Results of a multi-center randomized phase II AIO trial.
 
Alwin Krämer
Research Funding - Merck Serono (Inst)
 
Alexander Stein
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck KGaA; MSD; Roche
Speakers' Bureau - Amgen; Bayer; Bristol-Myers Squibb; Celgene; Lilly; Merck KGaA; Roche; Sanofi; Servier
Research Funding - Bristol-Myers Squibb (Inst); Merck KGaA (Inst); Roche (Inst); Sanofi (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck KGaA; Roche
 
Gerdt Huebner
No Relationships to Disclose
 
Michael Stahl
No Relationships to Disclose
 
Stefan Kasper
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD Oncology; Roche; Shire; Shire
Consulting or Advisory Role - Amgen; AstraZeneca; Baxalta; Bristol-Myers Squibb; Lilly; Merck Serono; MSD Oncology; Roche; Sanofi; SERVIER
Research Funding - Bristol-Myers Squibb; Celgene; Lilly; Merck Serono; SERVIER
Travel, Accommodations, Expenses - Amgen; Lilly; Merck Serono; Roche; Sanofi
Other Relationship - Amgen; Merck Serono; Sanofi
 
Albrecht Kretzschmar
Honoraria - Amgen; Eisai; Medac; Merck Serono; Novartis; Roche Pharma AG; Sanofi; SERVIER; Shire
Consulting or Advisory Role - Amgen; Roche Pharma AG; Shire; Teva
Travel, Accommodations, Expenses - Ipsen; Medac; Merck Serono; PharmaMar
 
Claus-Henning Kohne
No Relationships to Disclose
 
Viktor Grünwald
Stock and Other Ownership Interests - AstraZeneca; Bristol-Myers Squibb; MSD
Honoraria - Ars tempi; AstraZeneca; Bayer; Bristol-Myers Squibb; Cerulean Pharma; COCS GmbH; Eisai; EUSA Pharma; Exelixis; Ipsen; Janssen-Cilag; Lilly; MedKom Akademie; Merck Serono; MSD Oncology; NewConceptOncology; Novartis; Pfizer; PharmaMar; Promedior; Roche; Update Oncology
Consulting or Advisory Role - Bristol-Myers Squibb; Cerulean Pharma; ClinSol; Ipsen; Lilly; MSD Oncology; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb; Novartis (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Ipsen; MSD Oncology; Novartis; Pfizer
 
Ralf Hofheinz
Honoraria - Amgen; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Ipsen; Medac; Merck KGaA; Merck Sharp & Dome; Roche; Saladax Biomedical; Sanofi/Aventis
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Ipsen; Merck; Merck Sharp & Dome; Roche; Sanofi/Aventis
Research Funding - Amgen (Inst); Medac (Inst); Merck KGaA (Inst); Roche (Inst); Sanofi/Aventis (Inst)
 
Katharina Schütte
No Relationships to Disclose
 
Harald Löffler
No Relationships to Disclose
 
Carsten Bokemeyer
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Merck KGaA; Roche; Sanofi; Servier/Pfizer
Consulting or Advisory Role - AOK Health Insurance; Bayer Schering Pharma; GSO; Hexal; Lilly/ImClone; Merck Serono; Merck Sharp & Dohme; Mundipharma; Sanofi
Research Funding - several companies in coooperation for clincal studies and for preclinical laboratory work (at my institution more than 100 ongoing reserach projects) (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Serono; Pfizer; Sanofi
 
Gunnar Folprecht
Honoraria - Bristol-Myers Squibb; Lilly/ImClone; Merck KGaA; Merck Sharp & Dohme; Roche/Genentech; Sanofi/Aventis; SERVIER
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Merck KGaA; Merck Sharp & Dohme; Mundipharma; Roche/Genentech; Sanofi/Aventis; SERVIER
Research Funding - Merck KGaA